We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
201
DELISTED
Discover Financial Services
DFS
| $38K | 0.06% |
534
+525
| +5,833% | +$38.5K |
|
202
HF Sinclair
DINO
$16.1B
| $38K | 0.06% |
+554
| New | +$36.9K |
|
203
DexCom
DXCM
$27.2B
| $38K | 0.06% |
+1,616
| New | +$34.3K |
|
204
Erie Indemnity
ERIE
$11.2B
| $38K | 0.06% |
324
-107
| -25% | -$12.4K |
|
205
Empire State Realty Trust
ESRT
$941M
| $38K | 0.06% |
2,208
-24,654
| -92% | -$417K |
|
206
Edwards Lifesciences
EW
$48.3B
| $38K | 0.06% |
+774
| New | +$36.1K |
|
207
Fortinet
FTNT
$111B
| $38K | 0.06% |
+3,025
| New | +$35.8K |
|
208
Globe Life
GL
$13.3B
| $38K | 0.06% |
462
-2,203
| -83% | -$187K |
|
209
Guidewire Software
GWRE
$10.9B
| $38K | 0.06% |
424
-2,008
| -83% | -$178K |
|
210
Hawaiian Electric Industries
HE
$2.34B
| $38K | 0.06% |
1,105
-81
| -7% | -$2.75K |
|
211
Humana
HUM
$47.4B
| $38K | 0.06% |
+126
| New | +$36.9K |
|
212
Howmet Aerospace
HWM
$115B
| $38K | 0.06% |
+2,875
| New | +$42.7K |
|
213
Hexcel
HXL
$8.29B
| $38K | 0.06% |
570
-2,996
| -84% | -$204K |
|
214
International Flavors & Fragrances
IFF
$18.8B
| $38K | 0.06% |
304
-2,037
| -87% | -$266K |
|
215
Intel
INTC
$504B
| $38K | 0.06% |
+766
| New | +$40.7K |
|
|
OPLN
216
Openlane
OPLN
$4.13B
| $38K | 0.06% |
1,820
-10,513
| -85% | -$214K |
|
217
Leidos
LDOS
$13.9B
| $38K | 0.06% |
639
-6,296
| -91% | -$393K |
|
218
L3Harris
LHX
$55.8B
| $38K | 0.06% |
+260
| New | +$40.3K |
|
219
Las Vegas Sands
LVS
$30.5B
| $38K | 0.06% |
+497
| New | +$38K |
|
220
Mastercard
MA
$469B
| $38K | 0.06% |
191
-1,145
| -86% | -$215K |
|
221
McDonald's
MCD
$187B
| $38K | 0.06% |
+240
| New | +$38.9K |
|
222
MarketAxess Holdings
MKTX
$4.06B
| $38K | 0.06% |
190
-747
| -80% | -$155K |
|
223
Morningstar
MORN
$6.37B
| $38K | 0.06% |
294
-333
| -53% | -$38.1K |
|
224
National Fuel Gas
NFG
$7.8B
| $38K | 0.06% |
+721
| New | +$37.3K |
|
225
Northrop Grumman
NOC
$75.8B
| $38K | 0.06% |
+122
| New | +$40.3K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.